MedPath

AD-128

Generic Name
AD-128

Study of AD128 Versus Placebo in Obstructive Sleep Apnea

Phase 2
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Drug: Placebo
First Posted Date
2020-06-26
Last Posted Date
2021-09-27
Lead Sponsor
Istituto Auxologico Italiano
Target Recruit Count
20
Registration Number
NCT04449133
Locations
🇮🇹

Istituto Auxologico Italiano,Ospedale San Luca, Milano, Italy

Effect of AD128 to Treat Obstructive Sleep Apnea

Phase 2
Completed
Conditions
Sleep Apnea, Obstructive
Interventions
First Posted Date
2020-05-19
Last Posted Date
2021-08-06
Lead Sponsor
Raphael Heinzer
Target Recruit Count
15
Registration Number
NCT04394143
Locations
🇨🇭

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

© Copyright 2025. All Rights Reserved by MedPath